Phase II Study for the Transfer of Bone Marrow-Derived Mononuclear and Mesenchymal StemCells Into the Myocardium for the Treatment of Severe Coronary Ischemia

Trial Profile

Phase II Study for the Transfer of Bone Marrow-Derived Mononuclear and Mesenchymal StemCells Into the Myocardium for the Treatment of Severe Coronary Ischemia

Suspended
Phase of Trial: Phase II

Latest Information Update: 25 Jun 2014

At a glance

  • Drugs Autologous stem cell therapy (Primary)
  • Indications Angina pectoris; Coronary artery disease
  • Focus Adverse reactions
  • Sponsors TCA Cellular Therapy
  • Most Recent Events

    • 08 May 2014 Planned End Date changed from 1 Nov 2011 to 1 May 2014 as reported by ClinicalTrial.gov record.
    • 08 May 2014 Status changed from active, no longer recruiting to suspended as reported by ClinicalTrial.gov record.
    • 18 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top